Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design

INTRODUCTION: Non-inferiority (NI) analysis is not usually considered in the early phases of clinical development. In some negative phase II trials, a post-hoc NI analysis justified additional phase III trials that were successful. However, the risk of false positive achievements was not controlled...

Descripción completa

Detalles Bibliográficos
Autores principales: Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Pérez-García, José, Páez, David, Guerrero-Zotano, Ángel L., Garde-Noguera, Javier, Aguirre, Elena, Holgado, Esther, López-Miranda, Elena, Huang, Xin, Malfettone, Andrea, Llombart-Cussac, Antonio, Cortés, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733004/
https://www.ncbi.nlm.nih.gov/pubmed/33336109
http://dx.doi.org/10.1016/j.conctc.2020.100678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733004/
https://www.ncbi.nlm.nih.gov/pubmed/33336109
http://dx.doi.org/10.1016/j.conctc.2020.100678

Ejemplares similares